Search results
Results From The WOW.Com Content Network
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy, prompted by post-menopausal bleeding . Unlike the more common low-grade endometrioid endometrial adenocarcinoma ...
Survival rate trends. In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [ 8]
TNM staging system. The TNM Classification of Malignant Tumors ( TNM) is a globally recognised standard for classifying the anatomical extent of the spread of malignant tumours (cancer). It has gained wide international acceptance for many solid tumor cancers, but is not applicable to leukaemia or tumors of the central nervous system.
Triiodothyronine, also known as T3, is a thyroid hormone. It affects almost every physiological process in the body, including growth and development, metabolism, body temperature, and heart rate. [ 1]
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all cases. It develops when abnormal lung cells grow uncontrollably, forming a tumor. There are ...
Acinic cell carcinoma is a malignant tumor representing 2% of all salivary tumors. 90% of the time found in the parotid gland, 10% intraorally on buccal mucosa or palate. The disease presents as a slow growing mass, associated with pain or tenderness in 50% of the cases. Often appears pseudoencapsulated.
Triple-negative breast cancers comprise a very heterogeneous group of cancers. TNBC is the most challenging breast cancer type to treat. [5] Hormone therapy that is used for other breast cancers does not work for TNBC. [6] In its early stages, the cancer is typically treated through surgery, radiation and chemotherapy.
These have favorable prognosis, with 5-year survival rates of 97-99%. [7] Invasive carcinoma. This group constitutes the other 70-85%. [6] The most common type in this group is invasive ductal carcinoma, representing about 80% of invasive carcinomas. [6] In the US, 55% of breast cancers are invasive ductal carcinoma. [8]